A systematic review of the effectiveness of policies restricting access to pregabalin

A systematic review of the effectiveness of policies restricting access to pregabalin

Abstract Background Formularies often employ restriction policies to reduce pharmacy costs. Pregabalin, an alpha-2-delta ligand, is approved for treatment of fibromyalgia (FM); neuropathic pain (NeP) due to postherpetic neuralgia (PHN), diabetic peripheral neuropathy (pDPN), spinal cord injury; and...

Full description

Saved in:
Bibliographic Details
Main Authors: Brett R. Stacey (Author), Jonathan Liss (Author), Regina Behar (Author), Alesia Sadosky (Author), Bruce Parsons (Author), Elizabeth T. Masters (Author), Patrick Hlavacek (Author)
Format: Book
Published: BMC, 2017-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items